Morphologic Repertoire of Well-Differentiated Pancreatic Neuroendocrine Tumors (Pannets): A Clinicopathologic Analysis of 139 Cases

被引：0
|
作者：
Xue, Yue [1 ]
Reid, Michelle [1 ]
Pehlivanoglu, Burcin [2 ]
Tracht, Jessica [3 ]
Sarmiento, Juan M. [2 ]
Krasinskas, Alyssa [2 ]
Adsay, N. Volkan [4 ]
机构：
[1] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Emory Univ, Birmingham, AL USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1931
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [21] PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma
    Sangoi, Ankur R.
    Ohgami, Robert S.
    Pai, Rish K.
    Beck, Andrew H.
    McKenney, Jesse K.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2011, 24 (03) : 412 - 424
  • [22] Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis
    Pozzari, Marta
    Maisonneuve, Patrick
    Spada, Francesca
    Berruti, Alfredo
    Amoroso, Vito
    Cella, Chiara Alessandra
    Laffi, Alice
    Pellicori, Stefania
    Bertani, Emilio
    Fazio, Nicola
    CANCER TREATMENT REVIEWS, 2018, 71 : 39 - 46
  • [23] Clinicopathological Features and Prognostic Analysis of 227 Cases with Well-Differentiated Gastric Neuroendocrine Tumors
    Li, Y.
    Tan, H.
    Jie, C.
    Jie, L.
    Pan, Z.
    Yu, Z.
    Xiaokou, L.
    Jie, L.
    Panpan, Z.
    Jianming, X.
    Qian, X.
    Zhirong, Q.
    NEUROENDOCRINOLOGY, 2020, 110 : 91 - 91
  • [24] Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases
    Singhi, Aatur D.
    Klimstra, David S.
    HISTOPATHOLOGY, 2018, 72 (01) : 168 - 177
  • [25] Initial Treatment of Well-Differentiated Neuroendocrine Tumors
    Dasari, Arvind
    Yao, James
    ONCOLOGY-NEW YORK, 2014, 28 (11): : 945 - 947
  • [26] Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors
    Li, Yuanliang
    Fan, Guohui
    Yu, Fuhuan
    Tian, Chao
    Tan, Huangying
    NEUROENDOCRINOLOGY, 2021, 111 (12) : 1231 - 1237
  • [27] Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors
    Tan, Qing-quan
    Wang, Xing
    Yang, Le
    Chen, Yong-Hua
    Tan, Chun-lu
    Zhu, Xiao-mei
    Ke, Neng-wen
    Liu, Xu-Bao
    MEDICINE, 2020, 99 (24) : E20324
  • [28] Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
    Cheng, Yue-Juan
    Meng, Chang-Ting
    Ying, Hong-Yan
    Zhou, Jian-Feng
    Yan, Xiao-Yan
    Gao, Xin
    Zhou, Na
    Bai, Chun-Mei
    MEDICINE, 2018, 97 (45)
  • [29] BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs)
    Raj, Nitya Prabhakar
    Meyers, Paul A.
    Saltz, Leonard
    Reidy, Diane Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
    Asa, Sylvia L.
    La Rosa, Stefano
    Basturk, Olca
    Adsay, Volkan
    Minnetti, Marianna
    Grossman, Ashley B.
    ENDOCRINE PATHOLOGY, 2021, 32 (01) : 169 - 191
12345